Leon Cooperman, chairman and CEO of Omega Advisors, shared his views on politics, current favorite stock ideas and the market.
Here is the full uncut interview with ValueAct Capital CEO Jeff Ubben, along with exclusive bonus interview content available only for CNBC Pro subscribers.
Here is the full, uncut interview with Jack Dorsey, CEO of Twitter and Square.
Here is the full, uncut interview with John Watson, chairman and CEO of Chevron.
Here is the full, uncut interview with Federal Reserve Gov. Lael Brainard.
In a CNBC interview, JPMorgan Chase chief Jamie Dimon shared his views on negative interest rates and was upbeat on the U.S. economy.
In a CNBC exclusive interview Tuesday, Barclays CEO Jes Staley discusses his views on the company's restructuring and simplifying the business model.
Former hedge fund manager Phil Falcone joined CNBC for an exclusive interview to talk about his new business venture, HC2 holdings.
Check out the "Fast Money" exclusive interview with Nigerian Oil Minister Emmanuel Ibe Kachikwu.
Here is the full, uncut interview with Federal Reserve Bank of Minneapolis President Neel Kashkari.
Check out Mario Gabelli's views on Viacom and the media industry.
Check out Hayman Capital's Kyle Bass and his bearish views on China's banking system and currency.
Check out Goldman Sachs CEO Lloyd Blankfein latest revealing views on the global markets, China and oil.
Morgan Stanley CEO James Gorman shares his views on the stock market and the economy.
Check out Goldman Sachs' Gary Cohn latest revealing views on the global markets and oil.
JPMorgan CEO Jamie Dimon weighs in on the market sell-off this year and what could be next for stocks.
Check out Bridgewater Associates' Ray Dalio latest revealing views on the state of the world economy and markets.
As a potential capitulation gets underway, Larry Fink believes investors still need to find ways to put money to work.
Sage Therapeutics CEO Jeff Jonas shares his views on the recent sell-off in biotech stocks, along with what's in his pipeline.
Check out Boston Scientific CEO Michael Mahoney's revealing update on the state of the company's products.